Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4961-40-4
2. Triethylenetetramine Tetrahydrochloride
3. Triethylenetetramine, Tetrahydrochloride
4. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Tetrahydrochloride
5. 7360ure56q
6. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride
7. Trientine Tetrahydrochloride [usan]
8. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride
9. 1,2-ethanediamine, N1,n2-bis(2-aminoethyl)-, Hydrochloride (1:4)
10. Mfcd00012890
11. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride
12. Nsc-158271
13. Triethylenetetraminetetrahydrochloride
14. Einecs 225-604-3
15. 3,6-diazaoctane-1,8-diamine Tetrahydrochloride
16. Nsc 158271
17. Unii-7360ure56q
18. Cuprior (tn)
19. Cuvrior
20. Teta 4hcl
21. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Tetrahydrochloride
22. Dtxsid5063657
23. Triethylenetetramine Tetrahcl
24. Akos027320476
25. As-10237
26. Triethylenetetramine Tetrahydrochloride-d4
27. Db-051656
28. Ft-0635490
29. T1212
30. Trientine Tetrahydrochloride [who-dd]
31. Triethylenetetramine Tetrahydrochloride, 97%
32. D11649
33. 1,4,7,10-tetraazadecane Tetrahydrochloride
34. Q27266138
35. 2-ethanediamine,n,n'-bis(2-aminoethyl)-tetrahydrochloride
36. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Tetrahydrochloride
37. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine)tetrahydrochloride
Molecular Weight | 292.1 g/mol |
---|---|
Molecular Formula | C6H22Cl4N4 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 292.056907 g/mol |
Monoisotopic Mass | 290.059857 g/mol |
Topological Polar Surface Area | 76.1 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 49.7 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Cuprior is indicated for the treatment of Wilson's disease in adults, adolescents and children 5 years intolerant to D-penicillamine therapy.
A16AX
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Complete
Rev. Date : 2023-04-20
Pay. Date : 2023-03-15
DMF Number : 38120
Submission : 2023-03-09
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38371
Submission : 2023-05-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-10
Pay. Date : 2023-09-27
DMF Number : 38154
Submission : 2023-03-30
Status : Active
Type : II
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Trientine Tetrahydrochloride IH
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm : Plot No. 111 SIDCO Industrial Estate, Kakkalur Thiruvallur-602003 Tamil Nadu, In...
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-093
Start Marketing Date : 2022-10-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Details:
Cuprior (trientine tetrahydrochloride) is a copper chelator that removes absorbed copper from the body by forming a stable complex eliminated through urine, for treating Wilson disease.
Lead Product(s): Trientine Tetrahydrochloride
Therapeutic Area: Genetic Disease Brand Name: Cuprior
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 18, 2024
Lead Product(s) : Trientine Tetrahydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Orphalan Announces China Approval for Trientine Tetrahydrochloride Product
Details : Cuprior (trientine tetrahydrochloride) is a copper chelator that removes absorbed copper from the body by forming a stable complex eliminated through urine, for treating Wilson disease.
Brand Name : Cuprior
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 18, 2024
Details:
Cuvrior (trientine hydrochloride) is a copper chelator that forms a complex with absorbed copper and then gets eliminated through urinary excretion. It is available in US for the treatment of stable Wilson disease who are de-coppered and tolerant to penicillamine.
Lead Product(s): Trientine Tetrahydrochloride
Therapeutic Area: Genetic Disease Brand Name: Cuvrior
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 20, 2023
Lead Product(s) : Trientine Tetrahydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Orphalan Announces US Commercial Launch of Cuvrior™ for the Treatment of Wilson Disease
Details : Cuvrior (trientine hydrochloride) is a copper chelator that forms a complex with absorbed copper and then gets eliminated through urinary excretion. It is available in US for the treatment of stable Wilson disease who are de-coppered and tolerant to peni...
Brand Name : Cuvrior
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 20, 2023
Details:
Using this NCC measurement Cuvrior (trientine tetrahydrochloride) was determined to be non-inferior to penicillamine at primary endpoint of study (24 weeks), with same observation at end of extension phase of study in patients receiving maintenance penicillamine therapy.
Lead Product(s): Trientine Tetrahydrochloride
Therapeutic Area: Genetic Disease Brand Name: Cuvrior
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 30, 2022
Lead Product(s) : Trientine Tetrahydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Using this NCC measurement Cuvrior (trientine tetrahydrochloride) was determined to be non-inferior to penicillamine at primary endpoint of study (24 weeks), with same observation at end of extension phase of study in patients receiving maintenance penic...
Brand Name : Cuvrior
Molecule Type : Small molecule
Upfront Cash : Not Applicable
September 30, 2022
Details:
Cuvrior™ (trientine tetrahydrochloride) is an oral trientine formulation. In the U.S., trientine tetrahydrochloride has been granted Orphan Drug Designation for the treatment of Wilson’s disease.
Lead Product(s): Trientine Tetrahydrochloride
Therapeutic Area: Genetic Disease Brand Name: Cuvrior
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 22, 2022
Lead Product(s) : Trientine Tetrahydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Cuvrior™ (trientine tetrahydrochloride) is an oral trientine formulation. In the U.S., trientine tetrahydrochloride has been granted Orphan Drug Designation for the treatment of Wilson’s disease.
Brand Name : Cuvrior
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 22, 2022
Details:
Orphalan recently completed a global phase III trial, CHELATE, which met its primary efficacy endpoint by demonstrating that Cuvrior, a new salt of trientine (trientine tetrahydrochloride) was non-inferior to penicillamine as measured by non-ceruloplasmin copper.
Lead Product(s): Trientine Tetrahydrochloride
Therapeutic Area: Genetic Disease Brand Name: Cuvrior
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 02, 2022
Lead Product(s) : Trientine Tetrahydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Orphalan Announces FD Approval of Cuvrior™ for the Treatment of Adult Patients With Stable Wilso...
Details : Orphalan recently completed a global phase III trial, CHELATE, which met its primary efficacy endpoint by demonstrating that Cuvrior, a new salt of trientine (trientine tetrahydrochloride) was non-inferior to penicillamine as measured by non-ceruloplasmi...
Brand Name : Cuvrior
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 02, 2022
Regulatory Info : RX
Registration Country : USA
Brand Name : CUVRIOR
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2022-04-28
Application Number : 215760
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Cuprior
Dosage Form : Tablet
Dosage Strength : 150 mg
Packaging : Blisterpakning 72item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Turkey
Brand Name : SIPRYNE
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : SIPRYNE
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
RLD : Yes
TE Code :
Brand Name : CUVRIOR
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Approval Date : 2022-04-28
Application Number : 215760
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Regulatory Info :
Registration Country : Turkey
Brand Name : SIPRYNE
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 250MG
Brand Name : SIPRYNE
Approval Date :
Application Number :
Registration Country : Turkey
Global Sales Information
Dosage Form : Tablet
Dosage Strength : 150 mg
Price Per Pack (Euro) : 2,633.87
Published in :
Country : Norway
RX/OTC/DISCN :
Market Place
Patents & EXCLUSIVITIES
Exclusivity Code : NP
Exclusivity Expiration Date : 2025-04-28
Application Number : 215760
Product Number : 1
Exclusivity Details :
Exclusivity Code : ODE-401
Exclusivity Expiration Date : 2029-04-28
Application Number : 215760
Product Number : 1
Exclusivity Details :
ABOUT THIS PAGE
A Trientine Tetrahydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trientine Tetrahydrochloride, including repackagers and relabelers. The FDA regulates Trientine Tetrahydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trientine Tetrahydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trientine Tetrahydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trientine Tetrahydrochloride supplier is an individual or a company that provides Trientine Tetrahydrochloride active pharmaceutical ingredient (API) or Trientine Tetrahydrochloride finished formulations upon request. The Trientine Tetrahydrochloride suppliers may include Trientine Tetrahydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trientine Tetrahydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trientine Tetrahydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trientine Tetrahydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trientine Tetrahydrochloride DMFs exist exist since differing nations have different regulations, such as Trientine Tetrahydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trientine Tetrahydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trientine Tetrahydrochloride USDMF includes data on Trientine Tetrahydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trientine Tetrahydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trientine Tetrahydrochloride suppliers with USDMF on PharmaCompass.
A Trientine Tetrahydrochloride written confirmation (Trientine Tetrahydrochloride WC) is an official document issued by a regulatory agency to a Trientine Tetrahydrochloride manufacturer, verifying that the manufacturing facility of a Trientine Tetrahydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trientine Tetrahydrochloride APIs or Trientine Tetrahydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trientine Tetrahydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Trientine Tetrahydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trientine Tetrahydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trientine Tetrahydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trientine Tetrahydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trientine Tetrahydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trientine Tetrahydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trientine Tetrahydrochloride suppliers with NDC on PharmaCompass.
Trientine Tetrahydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trientine Tetrahydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trientine Tetrahydrochloride GMP manufacturer or Trientine Tetrahydrochloride GMP API supplier for your needs.
A Trientine Tetrahydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trientine Tetrahydrochloride's compliance with Trientine Tetrahydrochloride specifications and serves as a tool for batch-level quality control.
Trientine Tetrahydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trientine Tetrahydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trientine Tetrahydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trientine Tetrahydrochloride EP), Trientine Tetrahydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trientine Tetrahydrochloride USP).
LOOKING FOR A SUPPLIER?